[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Terrascent Corp (TSNDF)

Terrascent Corp (TSNDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Terrascent Corp 77 City Centre Drive Suite 501 - East Tower Mississauga A6 L5B 1M5 CAN

www.terrascend.com Employees: 1,038 P: 844-628-3100

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

TerrAscend is a cannabis operator with vertically integrated operations principally in Pennsylvania, New Jersey and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. TerrAscend is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 200,476
Enterprise Value, $K 377,166
Shares Outstanding, K 308,425
Float, K 210,870
% Float 68.37%
Short Interest, K 1,312
Short Float 0.43%
Days to Cover 1.00
Short Volume Ratio 0.47
% of Insider Shareholders 31.63%
% of Institutional Shareholders 5.83%

Financials:

Annual Sales, $ 260,560 K
Annual Net Income, $ -81,330 K
Last Quarter Sales, $ 65,540 K
Last Quarter Net Income, $ -6,950 K
EBIT, $ 52,740 K
EBITDA, $ 68,360 K

Growth:

1-Year Return 65.14%
3-Year Return -58.06%
5-Year Return -94.36%
5-Year Revenue Growth 76.26%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 05/07/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Year 40.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TSNDF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.69%
Return-on-Assets % -4.46%
Profit Margin % -31.21%
Debt/Equity 2.37
Price/Sales 0.78
Price/Cash Flow N/A
Price/Book 2.22
Book Value/Share 0.29
Interest Coverage -1.14
60-Month Beta 1.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.